These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29795424)

  • 21. CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation.
    de Koning C; Prockop S; van Roessel I; Kernan N; Klein E; Langenhorst J; Szanto C; Belderbos M; Bierings M; Boulad F; Bresters D; Cancio M; Curran K; Kollen W; O'Reilly R; Scaradavou A; Spitzer B; Versluijs B; Huitema A; Lindemans C; Nierkens S; Boelens JJ
    Blood; 2021 Feb; 137(6):848-855. PubMed ID: 33150379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Zhang R; Wang X; Hong M; Luo T; Zhao M; Shen H; Fang J; Li X; Zang S; Chen P; Nie D; Zheng P; Wu Q; Xia L
    Oncotarget; 2017 Apr; 8(14):23360-23375. PubMed ID: 28423578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human herpesvirus-6B infection in pediatric allogenic hematopoietic stem cell transplant patients: Risk factors and encephalitis.
    Miura H; Kawamura Y; Hattori F; Tanaka M; Kudo K; Ihira M; Yatsuya H; Takahashi Y; Kojima S; Sakaguchi H; Yoshida N; Hama A; Yoshikawa T
    Transpl Infect Dis; 2020 Feb; 22(1):e13203. PubMed ID: 31650671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reactivation of human herpesvirus 6 in pediatric allogeneic hematopoietic stem cell transplant recipients.
    Pawlowska AB; Karras NA; Liu H; DiMundo J; Cheng JC; Sun W; Armenian S; Yang D; Palmer JM; Bell A; Tahoun A; Tegtmeier B; Dadwal S; Rosenthal J
    Transpl Infect Dis; 2021 Feb; 23(1):e13453. PubMed ID: 32860467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis due to human herpesvirus 6B after hematopoietic cell transplantation and a review of the literature.
    Hill JA; Myerson D; Sedlak RH; Jerome KR; Zerr DM
    Transpl Infect Dis; 2014 Jun; 16(3):477-83. PubMed ID: 24703390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of post-transplant thymopoiesis with CD4
    Trovillion EM; Gloude NJ; Anderson EJ; Morris GP
    Bone Marrow Transplant; 2019 Jun; 54(6):917-920. PubMed ID: 30413809
    [No Abstract]   [Full Text] [Related]  

  • 28. Impact of low-dose anti-thymocyte globulin on immune reconstitution after allogeneic hematopoietic cell transplantation.
    Ito A; Kitano S; Tajima K; Kim Y; Tanaka T; Inamoto Y; Kim SW; Yamamoto N; Fukuda T; Okamoto S
    Int J Hematol; 2020 Jan; 111(1):120-130. PubMed ID: 31641956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA Sequencing of the
    Hill JA; Ikoma M; Zerr DM; Basom RS; Peddu V; Huang ML; Hall Sedlak R; Jerome KR; Boeckh M; Barcy S
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation.
    Wang LR; Dong LJ; Zhang MJ; Lu DP
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1031-7. PubMed ID: 17067909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome.
    Greco R; Crucitti L; Noviello M; Racca S; Mannina D; Forcina A; Lorentino F; Valtolina V; Rolla S; Dvir R; Morelli M; Giglio F; Barbanti MC; Lupo Stanghellini MT; Oltolini C; Vago L; Scarpellini P; Assanelli A; Carrabba MG; Marktel S; Bernardi M; Corti C; Clementi M; Peccatori J; Bonini C; Ciceri F
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2250-2255. PubMed ID: 27697585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune recovery after in vivo T-cell depletion myeloablative conditioning hematopoietic stem cell transplantation in severe beta-thalassemia children.
    Qin F; Shi L; Li Q; Zhang Z; Liu L; Li J; Yang G; Lai YR
    Eur J Haematol; 2019 Oct; 103(4):342-350. PubMed ID: 31276236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune Reconstitution Following TCRαβ/CD19-Depleted Hematopoietic Cell Transplantation for Hematologic Malignancy in Pediatric Patients.
    Arnold DE; MacMath D; Seif AE; Heimall JR; Wang Y; Monos D; Grupp SA; Bunin NJ
    Transplant Cell Ther; 2021 Feb; 27(2):169.e1-169.e9. PubMed ID: 33830028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
    Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
    Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation.
    Ward KN; Hill JA; Hubacek P; de la Camara R; Crocchiolo R; Einsele H; Navarro D; Robin C; Cordonnier C; Ljungman P;
    Haematologica; 2019 Nov; 104(11):2155-2163. PubMed ID: 31467131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute graft-versus-host disease: differing risk with differing graft sources and conditioning intensity.
    Johnston L
    Best Pract Res Clin Haematol; 2008 Jun; 21(2):177-92. PubMed ID: 18503985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlations of cytokine levels in cerebrospinal fluid and peripheral blood with outcome of HHV-6B encephalitis after hematopoietic stem cell transplantation.
    Takano K; Ogata M; Satou T; Miyazaki Y; Otsuka E; Saito N; Ueki T; Kako S; Fukuda T; Shirao K
    Transpl Infect Dis; 2019 Dec; 21(6):e13172. PubMed ID: 31520510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HHV-6B detection and host gene expression implicate HHV-6B as pulmonary pathogen after hematopoietic cell transplant.
    Hill JA; Lee YJ; Vande Vusse LK; Xie H; Chung EL; Waghmare A; Cheng GS; Zhu H; Huang ML; Hill GR; Jerome KR; Leisenring WM; Zerr DM; Gharib SA; Dadwal S; Boeckh M
    Nat Commun; 2024 Jan; 15(1):542. PubMed ID: 38228644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation.
    Minculescu L; Marquart HV; Ryder LP; Andersen NS; Schjoedt I; Friis LS; Kornblit BT; Petersen SL; Haastrup E; Fischer-Nielsen A; Reekie J; Sengelov H
    Front Immunol; 2019; 10():1997. PubMed ID: 31507601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD134 is a cellular receptor specific for human herpesvirus-6B entry.
    Tang H; Serada S; Kawabata A; Ota M; Hayashi E; Naka T; Yamanishi K; Mori Y
    Proc Natl Acad Sci U S A; 2013 May; 110(22):9096-9. PubMed ID: 23674671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.